Will the new cytogenetics replace the old cytogenetics?

M. Salman, S. C. Jhanwar, Harry Ostrer

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

With the advent of array-based comparative genomic hybridization technology, the analog cytogenetic analysis that has been used for the past 100 years could be replaced by the quantitative, microarray-based molecular analysis. Major advantages of the new array-based cytogenetic technologies are the high resolution and the high throughput. This technology is the first to offer an autonomous whole-chromosome analysis in one hybridization reaction for the detection of submicroscopic gains/losses. However, as with any new technology, it needs to be validated with regard to its performance in various applications (e.g. clinical genetic testing and cancer applications), comparative cost, and the data interpretation.

Original languageEnglish (US)
Pages (from-to)265-275
Number of pages11
JournalClinical Genetics
Volume66
Issue number4
DOIs
StatePublished - Oct 2004
Externally publishedYes

Fingerprint

Cytogenetics
Technology
Comparative Genomic Hybridization
Cytogenetic Analysis
Genetic Testing
Chromosomes
Costs and Cost Analysis
Neoplasms

Keywords

  • Comparative genomic hybridization
  • Cytogenetics
  • Genetic screening
  • Genome
  • Microarray
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Will the new cytogenetics replace the old cytogenetics? / Salman, M.; Jhanwar, S. C.; Ostrer, Harry.

In: Clinical Genetics, Vol. 66, No. 4, 10.2004, p. 265-275.

Research output: Contribution to journalArticle

Salman, M. ; Jhanwar, S. C. ; Ostrer, Harry. / Will the new cytogenetics replace the old cytogenetics?. In: Clinical Genetics. 2004 ; Vol. 66, No. 4. pp. 265-275.
@article{dc0b9247181a4b7f9a54da8d62f1cba1,
title = "Will the new cytogenetics replace the old cytogenetics?",
abstract = "With the advent of array-based comparative genomic hybridization technology, the analog cytogenetic analysis that has been used for the past 100 years could be replaced by the quantitative, microarray-based molecular analysis. Major advantages of the new array-based cytogenetic technologies are the high resolution and the high throughput. This technology is the first to offer an autonomous whole-chromosome analysis in one hybridization reaction for the detection of submicroscopic gains/losses. However, as with any new technology, it needs to be validated with regard to its performance in various applications (e.g. clinical genetic testing and cancer applications), comparative cost, and the data interpretation.",
keywords = "Comparative genomic hybridization, Cytogenetics, Genetic screening, Genome, Microarray, Single nucleotide polymorphism",
author = "M. Salman and Jhanwar, {S. C.} and Harry Ostrer",
year = "2004",
month = "10",
doi = "10.1111/j.1399-0004.2004.00316.x",
language = "English (US)",
volume = "66",
pages = "265--275",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Will the new cytogenetics replace the old cytogenetics?

AU - Salman, M.

AU - Jhanwar, S. C.

AU - Ostrer, Harry

PY - 2004/10

Y1 - 2004/10

N2 - With the advent of array-based comparative genomic hybridization technology, the analog cytogenetic analysis that has been used for the past 100 years could be replaced by the quantitative, microarray-based molecular analysis. Major advantages of the new array-based cytogenetic technologies are the high resolution and the high throughput. This technology is the first to offer an autonomous whole-chromosome analysis in one hybridization reaction for the detection of submicroscopic gains/losses. However, as with any new technology, it needs to be validated with regard to its performance in various applications (e.g. clinical genetic testing and cancer applications), comparative cost, and the data interpretation.

AB - With the advent of array-based comparative genomic hybridization technology, the analog cytogenetic analysis that has been used for the past 100 years could be replaced by the quantitative, microarray-based molecular analysis. Major advantages of the new array-based cytogenetic technologies are the high resolution and the high throughput. This technology is the first to offer an autonomous whole-chromosome analysis in one hybridization reaction for the detection of submicroscopic gains/losses. However, as with any new technology, it needs to be validated with regard to its performance in various applications (e.g. clinical genetic testing and cancer applications), comparative cost, and the data interpretation.

KW - Comparative genomic hybridization

KW - Cytogenetics

KW - Genetic screening

KW - Genome

KW - Microarray

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=4844228261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4844228261&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0004.2004.00316.x

DO - 10.1111/j.1399-0004.2004.00316.x

M3 - Article

C2 - 15355426

AN - SCOPUS:4844228261

VL - 66

SP - 265

EP - 275

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 4

ER -